B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran
Farinaz Safavi, Bardia Nourbakhsh, Amir Reza Azimi
Topics & Concepts
MedicineMultiple sclerosisAffect (linguistics)Coronavirus disease 2019 (COVID-19)Respiratory illnessSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakRespiratory systemImmunologyVirologyDiseaseIntensive care medicineInfectious disease (medical specialty)Internal medicineOutbreakPhilosophyLinguisticsMultiple Sclerosis Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research